CN114432212A - 一种石斛保湿抗炎面膜及其制备方法 - Google Patents
一种石斛保湿抗炎面膜及其制备方法 Download PDFInfo
- Publication number
- CN114432212A CN114432212A CN202011212851.4A CN202011212851A CN114432212A CN 114432212 A CN114432212 A CN 114432212A CN 202011212851 A CN202011212851 A CN 202011212851A CN 114432212 A CN114432212 A CN 114432212A
- Authority
- CN
- China
- Prior art keywords
- dendrobium
- inflammatory
- moisturizing
- mask
- stirring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003110 anti-inflammatory effect Effects 0.000 title claims abstract description 36
- 230000003020 moisturizing effect Effects 0.000 title claims abstract description 32
- 241001523681 Dendrobium Species 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title abstract description 8
- 241001076416 Dendrobium tosaense Species 0.000 claims abstract description 15
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims abstract description 13
- 241000208680 Hamamelis mollis Species 0.000 claims abstract description 12
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims abstract description 11
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims abstract description 10
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims abstract description 10
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 10
- 229960003237 betaine Drugs 0.000 claims abstract description 10
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 10
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 10
- 229940064064 purslane extract Drugs 0.000 claims abstract description 7
- 238000001816 cooling Methods 0.000 claims description 25
- 238000003756 stirring Methods 0.000 claims description 25
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 14
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 14
- 230000001804 emulsifying effect Effects 0.000 claims description 10
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 9
- 229960005323 phenoxyethanol Drugs 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 235000005152 nicotinamide Nutrition 0.000 claims description 8
- 239000011570 nicotinamide Substances 0.000 claims description 8
- 229960003966 nicotinamide Drugs 0.000 claims description 8
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 7
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 7
- 229920002125 Sokalan® Polymers 0.000 claims description 7
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 7
- 229960000458 allantoin Drugs 0.000 claims description 7
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 7
- 229960001631 carbomer Drugs 0.000 claims description 7
- 239000008367 deionised water Substances 0.000 claims description 7
- 229910021641 deionized water Inorganic materials 0.000 claims description 7
- 229920001285 xanthan gum Polymers 0.000 claims description 7
- 229940082509 xanthan gum Drugs 0.000 claims description 7
- 235000010493 xanthan gum Nutrition 0.000 claims description 7
- 239000000230 xanthan gum Substances 0.000 claims description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 5
- 238000007599 discharging Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000007689 inspection Methods 0.000 claims description 5
- 238000004321 preservation Methods 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 238000005070 sampling Methods 0.000 claims description 5
- 239000013543 active substance Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 239000003755 preservative agent Substances 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 2
- 238000001256 steam distillation Methods 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 239000004552 water soluble powder Substances 0.000 claims description 2
- 240000004638 Dendrobium nobile Species 0.000 claims 2
- 241000208681 Hamamelis virginiana Species 0.000 claims 1
- 230000001815 facial effect Effects 0.000 abstract description 12
- 229940118846 witch hazel Drugs 0.000 abstract description 4
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 abstract description 3
- 230000001914 calming effect Effects 0.000 abstract description 3
- 238000011084 recovery Methods 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 18
- 230000000694 effects Effects 0.000 description 10
- 150000004676 glycans Chemical class 0.000 description 6
- 229920001282 polysaccharide Polymers 0.000 description 6
- 239000005017 polysaccharide Substances 0.000 description 6
- 230000003712 anti-aging effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- KIUKXJAPPMFGSW-YXBJCWEESA-N (2s,4s,5r,6s)-6-[(2s,3r,5s,6r)-3-acetamido-2-[(3s,4r,5r,6r)-6-[(3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@@H]3[C@@H]([C@@H](O)C(O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)C(C(O)=O)O1 KIUKXJAPPMFGSW-YXBJCWEESA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 206010039792 Seborrhoea Diseases 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 230000037312 oily skin Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- RYAHJFGVOCZDEI-UFFNCVEVSA-N Dendrobine Chemical compound C([C@H]1CC[C@@H]2[C@@]31C)N(C)[C@@H]3[C@H]1[C@@H](C(C)C)[C@@H]2C(=O)O1 RYAHJFGVOCZDEI-UFFNCVEVSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- 241000219304 Portulacaceae Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- RYAHJFGVOCZDEI-CZKZLRAZSA-N dendrobine Natural products O=C1O[C@@H]2[C@H](C(C)C)[C@H]1[C@H]1[C@@]3(C)[C@@H]2N(C)C[C@H]3CC1 RYAHJFGVOCZDEI-CZKZLRAZSA-N 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical group O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种石斛保湿抗炎面膜,所述石斛保湿抗炎面膜以铁皮石斛提取液、甜菜碱、烟酰胺、透明质酸钠、金缕梅提取液、马齿苋提取液、甘草酸二钾为保湿抗炎的主要成分,实现深层保湿、恢复弹性、抗炎镇静肌肤。还公开了该面膜制备方法,方法简单且产品稳定。
Description
技术领域
本发明涉及化妆品领域,具体涉及一种石斛保湿抗炎面膜及其制备方法。
背景技术
随着经济与社会的不断发展,人们更加注重肌肤的护理与保养,随之而来的是大量各种护肤品的出现,主打各种修护效果。除了各类水、乳、霜、精华液等,其中面膜在皮肤护理中占据重要位置,针对各类皮肤特点定期敷用面膜成为人们日常护理的重要一节。如清洁面膜、保湿补水面膜、美白面膜、修复镇定面膜等。敷用面膜可以使油性皮肤脱脂,毛孔得到收缩,干燥缺水肌肤恢复光泽和水嫩,晒后红肿皮肤得到镇定褪红。面膜的使用方便且见效快,可以使皮肤细腻光滑,清爽洁白,将肌肤从日常的光照环境中解脱并得到安抚舒缓。清除脸上面膜时,脸上的老化角质层、毛孔里的深层污垢等会被同时带走,是肌肤清爽干净。
本发明是针对常见皮肤问题研发的一款保湿抗炎面膜,有日常保湿、屏障受损、炎症、泛红等的修复作用,以云南产铁皮石斛为主要活性成分,并辅以其他多种天然植物来源成分制作精华部分,铁皮石斛是由多种活性物成分组成,例如多糖、黄酮类、多酚、氨基酸、石斛胺碱等十多种生物活性成分。还有钙、钾、镁、锌等几十种微量元素。其提取物具有抗肿瘤、增强免疫力、抗氧化和抗衰老等作用和功效。多糖是铁皮石斛的主要活性成分,水溶性多糖含量达到22.7%,石斛生理活性的强弱与其多糖含量密切相关,多糖含量越高,质越重,嚼之粘性越有粘性,质量更优。膜布采用超细纤维材质,贴合面膜,精华承载量高。该发明满足市场人群需求同时安全无刺激,全植物活性成分能够更有效缓解皮肤状况。
发明内容
本发明的一个目的是提出一种石斛保湿抗炎面膜,该石斛保湿抗炎面膜以甜菜碱、烟酰胺、透明质酸钠、金缕梅提取液、马齿苋提取液、甘草酸二钾、铁皮石斛提取液为保湿抗炎的主要成分,实现深层保湿、恢复弹性、抗炎镇静肌肤。本发明的另一个目的是提出上述石斛保湿抗炎面膜的制备方法。
为了实现上述的第一个目的,本发明采用了以下设计方案:
一种石斛保湿抗炎面膜,该组合物按百分质量比计包括以下的组分:
作为优选,该组合物按质量百分比计包括以下的组分:
作为优选,该组合物按质量百分比计包括以下的组分:
作为优选所述的透明质酸钠为20KDa分子量的白色结晶粉末状物质。
作为优选所述的金缕梅提取液为透明提取液,以水蒸气蒸馏法提取制得。
作为优选所述的马齿苋提取液为水溶性棕色透明液体,固含量为24%。
作为优选所述的甘草酸二钾为白色水溶性粉末,有效物质含量不低于95%。
作为优选所述的铁皮石斛提取液为棕色液体,其中有效成分含量不小于20%。
上述石斛保湿抗炎面膜中还加入了0.3~0.6%的苯氧乙醇作为防腐剂,0.02~0.3%的氢氧化钠作为pH调节剂。
为了实现上述的第二个目的,本发明采用了以下技术方案:
一种制备上述石斛保湿抗炎面膜的方法,该方法包括以下步骤:
1)将去离子水、1,3-丁二醇、卡波姆、EDTA二钠、尿囊素、黄原胶、20KDa分子量透明质酸钠加入乳化锅,开启搅拌,升温至80-85℃,高速均质3-5分钟使物料分散溶解均匀,保温15-20分钟并在此过程消除料体里的气泡。保温结束后开始开冷却循环水降温。
2)降温至75℃时将芦芭油、甜菜碱、烟酰胺加入到乳化锅中,搅拌并适当均质1分钟使物料快速分散溶解,然后继续降温。
3)降温至50℃时加入三乙醇胺,并搅拌均匀,不可再开启均质。
4)降温至45℃以下时加入北美金缕梅提取液、马齿苋提取液、甘草酸二钾、铁皮石斛提取液、苯氧乙醇,继续搅拌15-20分钟。
5)停止搅拌,取样检测,检验合格后出料。
烟酰胺维生素B3的一种衍生物,可以抑制黑色素从黑素细胞到角质形成细胞的转运,能够减轻和预防皮肤在早期衰老过程中产生的肤色黯淡、发黄。
金缕梅提取液含单宁质多种如Ellagtannin和Hamamlitannin可以调节皮脂分泌、具保湿及嫩白作用,具有镇静、安抚的效果,对龟裂、晒伤、粉刺有改善效果。可有效帮助肌肤夜间的再生能力,放松以及缓和对於油性肌肤或是过敏的肌肤都有很优异的效果。有舒缓、收敛控油、抗菌的效果。
铁皮石斛提取液主要活性成分为铁皮石斛多糖,具有活化巨噬细胞、抗氧化、增强免疫力等作用。应用在护肤领域具有四大护肤功效。1.抗炎修复能提高受紫外线损伤的人体真皮纤维芽细胞存活量,可修复弹性纤维,让皮肤恢复原有的弹性和光泽;2.止痒舒敏;3.抗辐射经测试铁皮石斛提取物能降低紫外线对于人体皮肤细胞的DNA损伤;4.抗衰老经测试铁皮石斛提取物能提高细胞增殖活性,且在一定范围内用量增加,细胞增殖活性也显著提升,抗衰老作用极其突出。
甘草酸二钾为甘草酸的衍生物,具有抗炎、抗过敏、抗溃疡、促进上皮细胞组织再生等作用
马齿苋提取液壳达到抗皮肤过敏、抗炎、祛痘、去自由基和抗氧化,延缓皮肤衰老
具体实施方式
本发明提供的石斛保湿抗炎面膜是以甜菜碱、烟酰胺、透明质酸钠、金缕梅提取液、马齿苋提取液、甘草酸二钾、铁皮石斛提取液为保湿抗炎的主要成分,辅以化妆品常用保湿剂、防腐剂、pH调节剂及水制成。下面列举一部分具体实施例对本发明进行说明,但并不限制本发明内容。
实施例1
石斛保湿抗炎面膜:
组成上述石斛保湿抗炎面膜的组分及其百分数含量为:
组分 | 百分比(%) |
去离子水 | 73.87 |
1,3-丁二醇 | 6.0 |
卡波姆 | 0.15 |
尿囊素 | 0.15 |
EDTA二钠 | 0.05 |
透明质酸钠 | 0.15 |
黄原胶 | 0.05 |
芦芭油 | 1.0 |
甜菜碱 | 3.0 |
烟酰胺 | 3.0 |
三乙醇胺 | 0.13 |
金缕梅提取液 | 4.0 |
马齿苋提取液 | 3.0 |
甘草酸二钾 | 0.1 |
铁皮石斛提取液 | 5.0 |
苯氧乙醇 | 0.35 |
上述石斛保湿抗炎面膜的制备方法,包括下列步骤:
1)将去离子水、1,3-丁二醇、卡波姆、EDTA二钠、尿囊素、黄原胶、20KDa分子量透明质酸钠加入乳化锅,开启搅拌,升温至80-85℃,高速均质3-5分钟使物料分散溶解均匀,保温15-20分钟并在此过程消除料体里的气泡。保温结束后开始开冷却循环水降温。
2)降温至75℃时将芦芭油、甜菜碱、烟酰胺加入到乳化锅中,搅拌并适当均质1分钟使物料快速分散溶解,然后继续降温。
3)降温至50℃时加入三乙醇胺,并搅拌均匀,不可再开启均质。
4)降温至45℃以下时加入北美金缕梅提取液、马齿苋提取液、甘草酸二钾、铁皮石斛提取液、苯氧乙醇,继续搅拌15-20分钟。
5)停止搅拌,取样检测,检验合格后出料。
实施例2
石斛保湿抗炎面膜:
组成上述石斛保湿抗炎面膜的组分及其百分数含量为:
组分 | 百分比(%) |
去离子水 | 78.77 |
1,3-丁二醇 | 8.0 |
卡波姆 | 0.15 |
尿囊素 | 0.15 |
EDTA二钠 | 0.05 |
透明质酸钠 | 0.1 |
黄原胶 | 0.05 |
芦芭油 | 0.7 |
甜菜碱 | 2.5 |
烟酰胺 | 2.0 |
三乙醇胺 | 0.13 |
金缕梅提取液 | 2.0 |
马齿苋提取液 | 2.0 |
甘草酸二钾 | 0.05 |
铁皮石斛提取液 | 3.0 |
苯氧乙醇 | 0.35 |
上述石斛保湿抗炎面膜的制备方法,包括下列步骤:
1)将去离子水、1,3-丁二醇、卡波姆、EDTA二钠、尿囊素、黄原胶、20KDa分子量透明质酸钠加入乳化锅,开启搅拌,升温至80-85℃,高速均质3-5分钟使物料分散溶解均匀,保温15-20分钟并在此过程消除料体里的气泡。保温结束后开始开冷却循环水降温。
2)降温至75℃时将芦芭油、甜菜碱、烟酰胺加入到乳化锅中,搅拌并适当均质1分钟使物料快速分散溶解,然后继续降温。
3)降温至50℃时加入三乙醇胺,并搅拌均匀,不可再开启均质。
4)降温至45℃以下时加入北美金缕梅提取液、马齿苋提取液、甘草酸二钾、铁皮石斛提取液、苯氧乙醇,继续搅拌15-20分钟。
5)停止搅拌,取样检测,检验合格后出料。
实施例3
石斛保湿抗炎面膜:
组成上述石斛保湿抗炎面膜的组分及其百分数含量为:
上述石斛保湿抗炎面膜的制备方法,包括下列步骤:
1)将去离子水、1,3-丁二醇、卡波姆、EDTA二钠、尿囊素、黄原胶、20KDa分子量透明质酸钠加入乳化锅,开启搅拌,升温至80-85℃,高速均质3-5分钟使物料分散溶解均匀,保温15-20分钟并在此过程消除料体里的气泡。保温结束后开始开冷却循环水降温。
2)降温至75℃时将芦芭油、甜菜碱、烟酰胺加入到乳化锅中,搅拌并适当均质1分钟使物料快速分散溶解,然后继续降温。
3)降温至50℃时加入三乙醇胺,并搅拌均匀,不可再开启均质。
4)降温至45℃以下时加入北美金缕梅提取液、马齿苋提取液、甘草酸二钾、铁皮石斛提取液、苯氧乙醇,继续搅拌15-20分钟。
5)停止搅拌,取样检测,检验合格后出料。
本发明不受上述实施例的限制,上述实施例和说明书中描述的只是说明本发明的原理,在不脱离本发明精神和范围的前提下,本发明还会有各种变化和改进,这些变化和改进也有落入要求保护的本发明范围内。本发明的保护范围由其所附权利要求书及其等效无界定。
Claims (10)
4.根据权利要求1或2或3所述的一种石斛保湿抗炎面膜,其特征在于所述的金缕梅提取液为透明提取液,以水蒸气蒸馏法提取制得。
5.根据权利要求1或2或3所述的一种石斛保湿抗炎面膜,其特征在于所述的透明质酸钠为白色粉末状物质,其中活性物含量不小于99%,平均分子量为20kDa。
6.根据权利要求1或2或3所述的一种石斛保湿抗炎面膜,其特征在于所述的马齿苋提取液为水溶性棕色透明液体,固含量为24%。
7.根据权利要求1或2或3所述的一种石斛保湿抗炎面膜,其特征在于所述的甘草酸二钾为白色水溶性粉末,有效物质含量不低于95%。
8.根据权利要求1或2或3所述的一种石斛保湿抗炎面膜,其特征在于所述的铁皮石斛提取液为棕色液体,其中有效成分含量不小于20%。
9.根据权利要求1或2或3所述的一种石斛保湿抗炎面膜,其特征在于上述石斛保湿抗炎面膜中还加入了0.3%~0.6%的苯氧乙醇作为防腐剂,0.02%~0.3%的氢氧化钠作为pH调节剂。
10.一种制备权利要求1~9任意一项权利要求所述的石斛保湿抗炎面膜的方法,其特征在于该方法包括以下步骤:
1)将去离子水、1,3-丁二醇、卡波姆、EDTA二钠、尿囊素、黄原胶、20KDa分子量透明质酸钠加入乳化锅,开启搅拌,升温至80-85℃,高速均质3-5分钟使物料分散溶解均匀,保温15-20分钟并在此过程消除料体里的气泡。保温结束后开始开冷却循环水降温。
2)降温至75℃时将芦芭油、甜菜碱、烟酰胺加入到乳化锅中,搅拌并适当均质1分钟使物料快速分散溶解,然后继续降温。
3)降温至50℃时加入三乙醇胺,并搅拌均匀,不可再开启均质。
4)降温至45℃以下时加入北美金缕梅提取液、马齿苋提取液、甘草酸二钾、铁皮石斛提取液、苯氧乙醇,继续搅拌15-20分钟。
5)停止搅拌,取样检测,检验合格后出料。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011212851.4A CN114432212A (zh) | 2020-11-03 | 2020-11-03 | 一种石斛保湿抗炎面膜及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011212851.4A CN114432212A (zh) | 2020-11-03 | 2020-11-03 | 一种石斛保湿抗炎面膜及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114432212A true CN114432212A (zh) | 2022-05-06 |
Family
ID=81361851
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011212851.4A Pending CN114432212A (zh) | 2020-11-03 | 2020-11-03 | 一种石斛保湿抗炎面膜及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114432212A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107080716A (zh) * | 2017-04-17 | 2017-08-22 | 广西容县天顺石斛有限公司 | 石斛修护多效面膜及其制作方法 |
CN108096137A (zh) * | 2017-12-15 | 2018-06-01 | 广东盛美化妆品有限公司 | 一种含铁皮石斛提取物的炭黑面膜精华液及其制备方法 |
CN108451847A (zh) * | 2018-03-30 | 2018-08-28 | 珠海美高美健康科技有限公司 | 含有铁皮石斛提取物的面膜液及其制备方法和应用 |
CN109453096A (zh) * | 2018-12-11 | 2019-03-12 | 北京赛尔佳人化妆品有限公司 | 一种抗衰老护肤面膜精华液及其制备方法 |
CN110522658A (zh) * | 2019-09-23 | 2019-12-03 | 周璇 | 一种抗敏修复组合物及其制备方法 |
-
2020
- 2020-11-03 CN CN202011212851.4A patent/CN114432212A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107080716A (zh) * | 2017-04-17 | 2017-08-22 | 广西容县天顺石斛有限公司 | 石斛修护多效面膜及其制作方法 |
CN108096137A (zh) * | 2017-12-15 | 2018-06-01 | 广东盛美化妆品有限公司 | 一种含铁皮石斛提取物的炭黑面膜精华液及其制备方法 |
CN108451847A (zh) * | 2018-03-30 | 2018-08-28 | 珠海美高美健康科技有限公司 | 含有铁皮石斛提取物的面膜液及其制备方法和应用 |
CN109453096A (zh) * | 2018-12-11 | 2019-03-12 | 北京赛尔佳人化妆品有限公司 | 一种抗衰老护肤面膜精华液及其制备方法 |
CN110522658A (zh) * | 2019-09-23 | 2019-12-03 | 周璇 | 一种抗敏修复组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103191042A (zh) | 祛斑美白防皱保湿抗过敏抗衰老护肤剂 | |
CN104856892A (zh) | 一种富含生长因子的化妆品或护肤品制剂及其制备方法 | |
CN109998937B (zh) | 含有甘油葡糖苷(αGG)的系列化妆品及其制备方法 | |
CN107496195A (zh) | 一种重组人透明质酸组合物及其在化妆品中的应用 | |
CN105232442A (zh) | 一种植物抗氧化氨基酸洁面乳及其制备方法 | |
CN107714504A (zh) | 一种同人源胶原蛋白组合物及其在化妆品中应用 | |
CN103565728A (zh) | 一种黑果枸杞美白保湿柔肤水及其制备方法 | |
CN104414914A (zh) | 一种妊娠纹修复精华素 | |
CN103800224A (zh) | 护理皮肤用的美容组合物及美容方法 | |
CN112472653A (zh) | 一种祛痘芦荟胶及其制备方法 | |
CN111956575A (zh) | 一种含有芦荟活性物的美白抗衰保湿护肤品及其制备方法 | |
CN108685728A (zh) | 一种眼霜及其制备方法 | |
CN108261361A (zh) | 一种含有细胞生长因子的祛痘修复膏及其制备方法 | |
CN105267123A (zh) | 一种美白保湿爽肤水及其制备方法 | |
CN113384482B (zh) | 一种保湿嫩肤精华露及其制备方法 | |
CN114288221A (zh) | 一种有生发作用的含多肽和植物提取液的精华液的制备方法及其应用 | |
CN116270392B (zh) | 一种具有保湿功效的组合物及其应用 | |
CN112402308A (zh) | 一种多效舒缓保湿水及其制备方法 | |
CN108853002B (zh) | 抗衰组合物、面膜液和面膜 | |
CN108721202B (zh) | 一种玫瑰茄干细胞冻干粉眼霜及其制备方法 | |
CN111067860A (zh) | 一种用于美白和淡化痘印的干细胞分泌因子面膜及其制备方法 | |
CN114432212A (zh) | 一种石斛保湿抗炎面膜及其制备方法 | |
CN112245324B (zh) | 一种具有保湿功能的化妆品及其制备方法和用途 | |
CN110934785A (zh) | 一种美白保湿敏感肌肤用洗面奶及其制备方法 | |
CN113786371A (zh) | 一种制备越橘海藻面膜的组合物、面膜及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20220506 |
|
WD01 | Invention patent application deemed withdrawn after publication |